Tyr629
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Tyr629  -  CD6 (human)

Site Information
STSSGEWyQNFQPPP   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 450238

In vivo Characterization
Methods used to characterize site in vivo:
flow cytometry ( 1 ) , immunoprecipitation ( 1 , 2 ) , mass spectrometry ( 1 ) , mutation of modification site ( 3 ) , phospho-antibody ( 3 ) , western blotting ( 1 , 2 , 3 )
Disease tissue studied:
leukemia ( 1 ) , T cell leukemia ( 1 )
Relevant cell line - cell type - tissue:
Jurkat (T lymphocyte) ( 1 , 3 ) , lymphocyte ( 1 )

Upstream Regulation
Treatments:
anti-CD3 ( 3 )

Downstream Regulation
Effects of modification on CD6:
activity, induced ( 1 ) , molecular association, regulation ( 1 , 2 )
Induce interaction with:
GADS (human) ( 1 ) , GRB2 (human) ( 1 ) , SLP76 (human) ( 1 ) , TSAd (human) ( 1 , 2 )

References 

1

Breuning J, Brown MH (2017) T Cell Costimulation by CD6 Is Dependent on Bivalent Binding of a GADS/SLP-76 Complex. Mol Cell Biol 37
28289074   Curated Info

2

Hem CD, et al. (2017) CD6 and Linker of Activated T Cells are Potential Interaction Partners for T Cell-Specific Adaptor Protein. Scand J Immunol 85, 104-112
27896837   Curated Info

3

Kobarg J, et al. (1997) Analysis of the tyrosine phosphorylation and calcium fluxing of human CD6 isoforms with different cytoplasmatic domains. Eur J Immunol 27, 2971-80
9394826   Curated Info